Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1500 | RO-3306 | 3.16227766017 | -0.4377 | -0.14697 |
| HCC1500 | Rucaparib | 3.16227766017 | -0.1009 | -0.15380 |
| HCC1500 | Rucaparib | 3.16227766017 | 0.2312 | -0.18129 |
| HCC1500 | SHP099 | 3.16227766017 | 0.8970 | -0.15241 |
| HCC1143 | Ribociclib | 3.16227766017 | 0.6333 | -0.00033 |
| HCC1143 | LY3023414 | 3.16227766017 | 0.3263 | 0.02659 |
| HCC1395 | AZD2014 | 3.16227766017 | 0.3090 | 0.03698 |
| HCC1395 | GSK2334470 | 3.16227766017 | 1.0356 | -0.03119 |
| HCC1143 | Ribociclib | 3.16227766017 | 0.5572 | 0.00588 |
| HCC1937 | MK 1775 | 3.16227766017 | -0.0389 | 0.16053 |
| HCC1143 | Ribociclib | 3.16227766017 | 0.5129 | 0.01217 |
| HCC1937 | AZD2014 | 3.16227766017 | 0.3812 | 0.03098 |
| HCC1143 | LY3023414 | 3.16227766017 | 0.3593 | 0.01138 |
| HCC1143 | SHP099 | 3.16227766017 | 0.9259 | -0.00032 |
| HCC1143 | LY3023414 | 3.16227766017 | 0.2988 | 0.06605 |
| HCC1937 | AZD5363 | 3.16227766017 | 0.7341 | 0.01598 |
| HCC1143 | RO-3306 | 3.16227766017 | 0.3550 | 0.05759 |
| HCC1143 | RO-3306 | 3.16227766017 | 0.3545 | 0.06966 |
| HCC1143 | Rucaparib | 3.16227766017 | 0.8837 | -0.00520 |
| HCC1143 | Rucaparib | 3.16227766017 | 0.8551 | -0.00356 |
| HCC1143 | Senexin B | 3.16227766017 | 0.7308 | 0.00010 |
| HCC1395 | MK 1775 | 3.16227766017 | -0.1856 | 0.09273 |
| HCC1143 | SHP099 | 3.16227766017 | 0.9161 | -0.00376 |
| MDA-MB-157 | LY3023414 | 3.16227766017 | 0.0476 | 0.13033 |
| MDA-MB-157 | LY3023414 | 3.16227766017 | 0.0148 | 0.09040 |